Pacemaker Market Analysis, Size, Trends | Global | 2019-2025 | MedCore | Segmented by: Product Type (Single-Chamber & Dual-Chamber Pacemakers)

  • Year: 2020
  • Scope: 2015-2025
  • Region: Africa, Middle East, North America, Asia-Pacific, Europe, Latin America
  • Pages: 252
  • Published Date: 11/09/2020
  • Type: MedCore

In 2020, the global pacemaker market size was valued at $2.26 billion, with over 450,000 pacemaker procedures performed annually. The market size is expected to further increase over the forecast period and reach $2.6 billion in 2025.

Throughout this medical market research, we analyzed global pacemaker companies across more than 70 countries and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

Our analysts meticulously researched for up to 3 to 4 months to put together a Global Cardiac Rhythm Management Device MedSuite, which is a comprehensive analysis of a group of healthcare markets. This MedCore is one portion of that analysis that focuses on the Pacemaker market segment and provides further detailed segmentation to get a much more granular set of market data.


  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Pacemaker Procedure Volumes
  • Market Forecasts Until 2025, and Historical Data to 2015
  • Market Drivers & Limiters for Each Pacemaker market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

Pacemaker Market Insights

New technologies are constantly emerging in the cardiac rhythm management and ablation market. The capabilities and battery lifespan of pacemakers have increased in the last decade. Over the forecast period, wireless technology is expected to make it easier for doctors to maintain and adjust pacemaker function. In addition, new technologies are expected to keep selling prices high and lead to a higher number of devices sold.

Global Pacemaker Market Value Growth, 2015-2025

The United States is the dominant market for Pacemakers with a total market value expected to reach $2 billion in 2025. However, a tight competitive landscape signals a slowdown in growth rates for the American market. Europe is the second-largest market for Pacemakers with a total market value expected to reach €411 million in 2025. Adoption for leadless pacemaker devices is slow in the E.U. therefore impacting the overall growth rates.

Pacemaker Market Share Insights

Global Pacemaker Market Share Leaders

By 2020, Medtronic led the pacemaker market with single-chamber, dual-chamber, and leadless devices. Medtronic pioneered the development of pacemakers and has long been the leading manufacturer in the pacemaker market.

Abbott was the second-leading competitor in the Global Pacemaker market by 2020. Abbott entered the market in 2017 with the complete acquisition of St. Jude Medical. The company has a very competitive pricing model and leverages off relationships from its electrophysiology and cardiac ablation business to gain more accounts within the CRM market.

Boston Scientific was the third-leading competitor in the Global Pacemaker market. The company competes in the market with its ACCOLADE™ and ESSENTIO™ line of MRI-compatible pacemakers.

Report Regional Coverage

Throughout this research series, iData Research has covered several regions in great detail. Each region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)

Pacemaker Market Segmentation

Global Pacemaker Market Segmentaiton


Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report


TABLE OF CONTENTS ILIST OF FIGURES XILIST OF CHARTS XVIEXECUTIVE SUMMARY 1GLOBAL PACEMAKER MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 7MARKET DEVELOPMENTS 8PROCEDURE NUMBERS 8MARKETS INCLUDED 9REGIONS INCLUDED 10VERSION HISTORY 12RESEARCH METHODOLOGY 13Step 1: Project Initiation & Team Selection 13Step 2: Prepare Data Systems and Perform Secondary Research 16Step 3: Preparation for Interviews & Questionnaire Design 18Step 4: Performing Primary Research 19Step 5: Research Analysis: Establishing Baseline Estimates 21Step 6: Market Forecast and Analysis 22Step 7: Identify Strategic Opportunities 24Step 8: Final Review and Market Release 25Step 9: Customer Feedback and Market Monitoring 26


2.1 INTRODUCTION 272.2 TYPES OF ARRHYTHMIAS 282.2.1 Atrial Fibrillation 282.2.2 Bradycardia 292.2.3 Conduction Disorders Bundle Branch Block Heart Block 302.2.3.3 Long QT Syndrome (LQTS) 312.2.4 Premature Contractions: PACs and PVCs 312.2.5 Tachycardia 322.2.6 Ventricular Fibrillation 322.2.7 Other Rhythm Disorders 332.2.7.1 Adams-Stokes Disease 332.2.7.2 Atrial Flutter 332.2.7.3 Sick Sinus syndrome 342.2.7.4 Sinus Arrhythmia 342.2.7.5 Wolff-Parkinson-White Syndrome (WPW) 342.2.8 Types of Arrhythmia in Children 342.3 HEART FAILURE 342.4 CARDIAC ARREST 352.5 PATIENT DEMOGRAPHICS 372.5.1 Atrial Fibrillation 372.5.2 Bradycardia 372.5.3 Conduction Disorders 382.5.4 Premature Contractions – PACs and PVCs 392.5.5 Tachycardia 402.5.6 Ventricular Fibrillation 402.5.7 Other Rhythm Disorders 41


3.1 INTRODUCTION 423.2 PRODUCT PORTFOLIOS 423.2.1 Pacemakers 423.3 FDA RECALLS 453.3.1 Abbott 453.3.2 Boston Scientific 463.3.3 Medtronic 523.4 CLINICAL TRIALS 533.4.1 Pacemakers 53


4.1 INTRODUCTION 584.1.1 Single and Dual-Chamber Devices 584.1.2 MRI-Compatible Pacemaker 594.1.3 Leadless Pacemaker 594.1.4 Initial Placement and Replacement of Pacemakers 604.2 MARKET OVERVIEW 614.3 TREND ANALYSIS BY SEGMENT 664.4 DRIVERS AND LIMITERS 694.4.1 Market Drivers 694.4.2 Market Limiters 704.5 COMPETITIVE MARKET SHARE ANALYSIS 734.6 MERGERS AND ACQUISITIONS 774.7 COMPANY PROFILES 784.7.1 Abbott 784.7.2 Biosense Webster 794.7.3 Biotronik 804.7.4 Boston Scientific 814.7.5 Cardiac Science 834.7.6 GE Healthcare 844.7.7 Medtronic 854.7.8 MicroPort 864.7.9 ZOLL 884.8 SWOT ANALYSIS 894.8.1 Abbott 894.8.2 Biosense Webster 914.8.3 Biotronik 924.8.4 Boston Scientific 934.8.5 Cardiac Science 944.8.6 GE Healthcare 954.8.7 Medtronic 964.8.8 MicroPort 974.8.9 ZOLL 99


5.1 INTRODUCTION 1005.2 PROCEDURES 1015.2.1 Global Procedures 1015.2.2 North America Procedures 1035.2.2.1 Canada 1055.2.2.2 U.S. 1055.2.3 Latin America Procedures 1065.2.3.1 Argentina 1085.2.3.2 Brazil 1085.2.3.3 Chile 1085.2.3.4 Colombia 1095.2.3.5 Jamaica 1095.2.3.6 Mexico 1105.2.3.7 Peru 1105.2.3.8 Venezuela 1115.2.3.9 Rest of Latin America 1115.2.4 Western Europe Procedures 1125.2.4.1 Austria 1145.2.4.2 Benelux 1145.2.4.3 France 1145.2.4.4 Germany 1155.2.4.5 Italy 1155.2.4.6 Portugal 1165.2.4.7 Scandinavia 1165.2.4.8 Spain 1175.2.4.9 Switzerland 1175.2.4.10 United Kingdom 1175.2.4.11 Rest of Western Europe 1195.2.5 Central & Eastern Europe Procedures 1205.2.5.1 Baltic States 1225.2.5.2 Bulgaria 1225.2.5.3 Croatia 1225.2.5.4 Czech Republic 1235.2.5.5 Greece 1235.2.5.6 Hungary 1245.2.5.7 Kazakhstan 1245.2.5.8 Poland 1255.2.5.9 Romania 1255.2.5.10 Russia 1255.2.5.11 Turkey 1265.2.5.12 Ukraine 1265.2.5.13 Rest of Central & Eastern Europe 1275.2.6 Middle East Procedures 1285.2.6.1 Bahrain 1305.2.6.2 Iran 1305.2.6.3 Israel 1305.2.6.4 Kuwait 1315.2.6.5 Oman 1315.2.6.6 Qatar 1325.2.6.7 Saudi Arabia 1325.2.6.8 United Arab Emirates 1335.2.6.9 Rest of Middle East 1335.2.7 Asia-Pacific Procedures 1345.2.7.1 Australia 1375.2.7.2 Brunei 1375.2.7.3 Cambodia 1375.2.7.4 China 1385.2.7.5 Hong Kong 1385.2.7.6 India 1395.2.7.7 Indonesia 1395.2.7.8 Japan 1405.2.7.9 Malaysia 1405.2.7.10 Myanmar 1405.2.7.11 New Zealand 1415.2.7.12 Singapore 1415.2.7.13 South Korea 1425.2.7.14 Taiwan 1425.2.7.15 Thailand 1435.2.7.16 The Philippines 1435.2.7.17 Vietnam 1445.2.7.18 Rest of Asia Pacific 1445.2.8 Africa Procedures 1455.2.8.1 Algeria 1475.2.8.2 Egypt 1475.2.8.3 Ghana 1475.2.8.4 Kenya 1485.2.8.5 Libya 1485.2.8.6 Morocco 1495.2.8.7 Nigeria 1495.2.8.8 South Africa 1505.2.8.9 Sudan 1505.2.8.10 Uganda 1505.2.8.11 Rest of Africa 151


6.1 INTRODUCTION 1526.1.1 Single and Dual-Chamber Devices 1526.1.2 MRI-Compatible Pacemaker 1536.1.3 Initial Placement and Replacement of Pacemakers 1536.1.4 Countries Included 1546.2 MARKET OVERVIEW 1556.2.1 Total Single-Chamber Pacemaker Market 1586.2.1.1 New Placement Single-Chamber Pacemaker Market 1606.2.1.2 Replacement Single-Chamber Pacemaker Market 1616.2.2 Total Dual-Chamber Pacemaker Market 1626.2.2.1 New Placement Dual-Chamber Pacemaker Market 1646.2.2.2 Replacement Dual-Chamber Pacemaker Market 165


7.1 INTRODUCTION 1677.1.1 Single and Dual-Chamber Devices 1677.1.2 MRI-Compatible Pacemaker 1687.1.3 Initial Placement and Replacement of Pacemakers 1687.1.4 Countries Included 1697.2 MARKET OVERVIEW 1707.2.1 Total Single-Chamber Pacemaker Market 1737.2.1.1 New Placement Single-Chamber Pacemaker Market 1757.2.1.2 Replacement Single-Chamber Pacemaker Market 1767.2.2 Total Dual-Chamber Pacemaker Market 1777.2.2.1 New Placement Dual-Chamber Pacemaker Market 1797.2.2.2 Replacement Dual-Chamber Pacemaker Market 180


8.1 INTRODUCTION 1818.1.1 Single and Dual-Chamber Devices 1818.1.2 MRI-Compatible Pacemaker 1828.1.3 Initial Placement and Replacement of Pacemakers 1828.1.4 Countries Included 1838.2 MARKET OVERVIEW 1848.2.1 Total Single-Chamber Pacemaker Market 1878.2.1.1 New Placement Single-Chamber Pacemaker Market 1898.2.1.2 Replacement Single-Chamber Pacemaker Market 1908.2.2 Total Dual-Chamber Pacemaker Market 1918.2.2.1 New Placement Dual-Chamber Pacemaker Market 1938.2.2.2 Replacement Dual-Chamber Pacemaker Market 194


9.1 INTRODUCTION 1959.1.1 Single and Dual-Chamber Devices 1959.1.2 MRI-Compatible Pacemaker 1969.1.3 Initial Placement and Replacement of Pacemakers 1969.1.4 Countries Included 1979.2 MARKET OVERVIEW 1989.2.1 Total Single-Chamber Pacemaker Market 2019.2.1.1 New Placement Single-Chamber Pacemaker Market 2039.2.1.2 Replacement Single-Chamber Pacemaker Market 2049.2.2 Total Dual-Chamber Pacemaker Market 2059.2.2.1 New Placement Dual-Chamber Pacemaker Market 2079.2.2.2 Replacement Dual-Chamber Pacemaker Market 208


10.1 INTRODUCTION 20910.1.1 Single and Dual-Chamber Devices 20910.1.2 MRI-Compatible Pacemaker 21010.1.3 Initial Placement and Replacement of Pacemakers 21010.1.4 Countries Included 21110.2 MARKET OVERVIEW 21210.2.1 Total Single-Chamber Pacemaker Market 21510.2.1.1 New Placement Single-Chamber Pacemaker Market 21710.2.1.2 Replacement Single-Chamber Pacemaker Market 21810.2.2 Total Dual-Chamber Pacemaker Market 21910.2.2.1 New Placement Dual-Chamber Pacemaker Market 22110.2.2.2 Replacement Dual-Chamber Pacemaker Market 222For a Full Table of Contents, please contact iData.
The Pacemaker Market Report Suite | Global | 2019-2025 | MedCore includes analysis on the following companies currently active in this market:
  • Medtronic
  • Abbott
  • Boston Scientific
  • Biotronik
  • MicroPort
  • Lepu Medical
  • Oscor
  • Osypka Medical
  • Vitatron
  • Pacetronix
  • Others

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology